AFBF, along with U.S. House representatives, is urging the administration to remain firm in its efforts to see China establish a transparent, predictable and practical approach to approving biotechnology traits for import. Next month the U.S.-China Joint Commission on Commerce and Trade will meet and AFBF is hopeful biotech approvals will top the agenda. AFBF economist Veronica Nigh explained in a recent Newsline that stable regulations from China would benefit U.S. agriculture.
“Buyers in China want to purchase high-quality U.S. biotech crop. They’ve shown that year after year with increasing purchases,” Nigh said. Further, “We want to make sure that the U.S. government and the Chinese government are all on the same page to make sure all of that good quality crop that is so bountiful this year can find a home in different export markets including China.”